Xeris Biopharma Holdings, Inc. (XERS) Deep Dive Video

Summary

Xeris is transforming from a leveraged specialty biotech into a self-funding, high-margin growth platform powered by Recorlev’s rapid ramp, proprietary formulation technology, and a potentially blockbuster weekly levothyroxine pipeline asset.

View XERS stock page · Read the XERS research report

Loading the video player…